Beihai Kangcheng-B (01228.HK) intends to appoint Baiyang Pharmaceutical subsidiary as the exclusive contract sales organization to promote the group's products.
Zhichong Finance APP news, Beihai Kangcheng-B (01228.HK) announced that on August 11, 2025, two of the group's subsidiary companies officially established a strategic partnership with a subsidiary of Qingdao Baiyang Medicine Co., Ltd. (301015.SZ) (Baiyang Medicine) - (Baiyang subsidiary company).
Latest